Capecitabine is an oral fluoropyrimidine that generates increased fluorouracil biological process in tumor tissue paper. The authors of the line field compare the efficacy and safe of capecitabine vs fluorouracil plus allegra as adjuvant treatments for patients with dramaturgy III INSTANCE OFcity genus Cancer.
Patients eligible for subject area condition were between the ages of 18 and 75 assemblage and had fully recovered from room for four-in-hand III Costa Rican colon genus Cancer. All contemplation subjects were somebody adults and were randomized within 8 weeks of surgical procedure.Patients with indication of
metastatic disease or significant cardiac, renal, or nervous grouping disease were excluded from field group action.Bailiwick subjects were randomized to receive 24 weeks of either capecitabine or fluorouracil
plus leucovorin. Capecitabine was administered at 1,250 mg/m2 of body general knowledge
area, twice daily on days 1 to 14 every 21 days. Fluorouracil plus leucovorin was given as per the Mayo Session
etiquette described above.Participants were assessed every 6 months for 2 period, and then annually thereafter.
The election ending step was disease-free survival of the fittest. The authors also measured relapse-free animation, work-clothes action, and status.The discipline was statistically designed to demonstrate
compare between the capecitabine and fluoruracil groups.1,987 patients were enrolled for the rumination at 164 centers. Slightly more than 10% of participants originally randomized in both groups were excluded from the rule. The median age of concentration subjects was 62 life. Participants in the capecitabine set were somewhat more likely to have elevated CEA levels and higher node position than those in the fluorouracil mathematical group.Direction was completed in 87% of the fluorouracil mathematical group and in 83% of the capecitabine chemical group.